Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.
3.
4.

Granisetron: new insights into its use for the treatment of chemotherapy-induced nausea and vomiting.

Tan M.

Expert Opin Pharmacother. 2003 Sep;4(9):1563-71. Review.

PMID:
12943486
6.

A review of granisetron, 5-hydroxytryptamine3 receptor antagonists, and other antiemetics.

Hsu ES.

Am J Ther. 2010 Sep-Oct;17(5):476-86. doi: 10.1097/MJT.0b013e3181ea7821. Review.

PMID:
20844345
7.
8.

Prevention and treatment of postoperative nausea and vomiting.

Kovac AL.

Drugs. 2000 Feb;59(2):213-43. Review.

PMID:
10730546
9.

[Recent improvements in antiemetic therapy].

Roila F, Palladino MA, Ciccarese G, Basurto C.

Tumori. 1997;83(2 Suppl):S3-14. Review. Italian.

PMID:
9235727
10.
11.

Ondansetron. An update of its therapeutic use in chemotherapy-induced and postoperative nausea and vomiting.

Markham A, Sorkin EM.

Drugs. 1993 Jun;45(6):931-52. Review. Erratum in: Drugs 1993 Aug;46(2):268.

PMID:
7691500
12.

A meta-analysis comparing the efficacy of four 5-HT3-receptor antagonists for acute chemotherapy-induced emesis.

Jordan K, Hinke A, Grothey A, Voigt W, Arnold D, Wolf HH, Schmoll HJ.

Support Care Cancer. 2007 Sep;15(9):1023-33. Epub 2007 Jan 5.

PMID:
17205281
15.
16.

Palonosetron: in the prevention of nausea and vomiting.

Yang LP, Scott LJ.

Drugs. 2009 Nov 12;69(16):2257-78. doi: 10.2165/11200980-000000000-00000. Review.

PMID:
19852528
17.

The safety and efficacy of prophylactic ondansetron in patients undergoing modified radical mastectomy.

Sadhasivam S, Saxena A, Kathirvel S, Kannan TR, Trikha A, Mohan V.

Anesth Analg. 1999 Dec;89(6):1340-5.

PMID:
10589605
18.

Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial.

Saito M, Aogi K, Sekine I, Yoshizawa H, Yanagita Y, Sakai H, Inoue K, Kitagawa C, Ogura T, Mitsuhashi S.

Lancet Oncol. 2009 Feb;10(2):115-24. doi: 10.1016/S1470-2045(08)70313-9. Epub 2009 Jan 8. Erratum in: Lancet Oncol. 2010 Mar;11(3)226.

PMID:
19135415
19.

Efficacy and safety of palonosetron for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV): a systematic review and meta-analysis of randomized controlled trials.

Popovic M, Warr DG, Deangelis C, Tsao M, Chan KK, Poon M, Yip C, Pulenzas N, Lam H, Zhang L, Chow E.

Support Care Cancer. 2014 Jun;22(6):1685-97. doi: 10.1007/s00520-014-2175-6. Epub 2014 Mar 4. Review.

PMID:
24590374
20.

Spectrum of use and tolerability of 5-HT3 receptor antagonists.

Haus U, Späth M, Färber L.

Scand J Rheumatol Suppl. 2004;119:12-8. Review.

PMID:
15515406
Items per page

Supplemental Content

Write to the Help Desk